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Abstract
R2-like ligand-binding oxidases (R2lox) assemble a heterodinuclear Mn/Fe cofactor which performs reductive dioxygen 
 (O2) activation, catalyzes formation of a tyrosine–valine ether cross-link in the protein scaffold, and binds a fatty acid in a 
putative substrate channel. We have previously shown that the N-terminal metal binding site 1 is unspecific for manganese 
or iron in the absence of  O2, but prefers manganese in the presence of  O2, whereas the C-terminal site 2 is specific for iron. 
Here, we analyze the effects of amino acid exchanges in the cofactor environment on cofactor assembly and metalation 
specificity using X-ray crystallography, X-ray absorption spectroscopy, and metal quantification. We find that exchange of 
either the cross-linking tyrosine or the valine, regardless of whether the mutation still allows cross-link formation or not, 
results in unspecific manganese or iron binding at site 1 both in the absence or presence of  O2, while site 2 still prefers iron 
as in the wild-type. In contrast, a mutation that blocks binding of the fatty acid does not affect the metal specificity of either 
site under anoxic or aerobic conditions, and cross-link formation is still observed. All variants assemble a dinuclear trivalent 
metal cofactor in the aerobic resting state, independently of cross-link formation. These findings imply that the cross-link 
residues are required to achieve the preference for manganese in site 1 in the presence of  O2. The metalation specificity, 
therefore, appears to be established during the redox reactions leading to cross-link formation.
Keywords Di-metal carboxylate protein · Ferritin · Ribonucleotide reductase · R2-like ligand-binding oxidase · X-ray 
crystallography
Abbreviations
BMM  Bacterial multicomponent monooxygenase
RNR  Ribonucleotide reductase
R2c  Class Ic RNR R2 protein
R2lox  R2-like ligand-binding oxidase
TXRF  Total-reflection X-ray fluorescence
wt  Wild-type
XANES  X-ray absorption near edge structure
XAS  X-ray absorption spectroscopy
Introduction
Enzymes with a di-metal carboxylate cofactor catalyze 
numerous essential reactions and in particular reductive 
dioxygen  (O2) activation in all kingdoms of life [1–5]. 
Three different combinations of manganese and iron have 
been found to constitute their cofactors. A diiron center 
is found in bacterial multicomponent monooxygenases 
(BMMs) as well as in the R2 subunit of class Ia ribonucle-
otide reductases (RNRs) [6–9]. In both groups the cofac-
tor reduces  O2, resulting in a high-valent metal–oxygen 
cofactor. In BMMs, this state catalyzes two-electron redox 
reactions, such as the hydroxylation of methane to metha-
nol [7]. In contrast, in class Ia R2 proteins an electron 
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from an exogenous donor is injected during  O2 activation, 
resulting in a metal center that carries out a one-electron 
oxidation of a nearby tyrosine residue [6, 10]. The tyrosyl 
radical then initiates ribonucleotide reduction in the R1 
subunit [6, 8, 9]. In class Ib RNRs, a dimanganese cofac-
tor undergoes similar reactions, although it is activated by 
superoxide, which is provided by an additional flavodoxin 
subunit [11–17]. In the recently proposed class Id RNRs, 
which also bind a dimanganese cofactor, the radical equiv-
alent appears to be stored at the metal site rather than at a 
tyrosine [18, 19]. Notably, a metal-free class Ie was also 
recently discovered [20–22]. The third metal combination 
identified to date is a heterodinuclear manganese/iron 
cofactor with the manganese ion occupying the N-terminal 
metal-binding site (site 1) [23–26]. This type of cofactor 
is found in class Ic R2 proteins (R2c), which store a radi-
cal equivalent on the cofactor after  O2 reduction [27–29]. 
A related group of proteins with a similar Mn/Fe cofactor 
is termed R2-like ligand-binding oxidases (R2lox) [25, 
26]. The physiological function of R2lox proteins has not 
yet been identified. Following  O2 activation, their cofac-
tor catalyzes a two-electron redox reaction which results 
in the formation of a tyrosine–valine ether cross-link in 
the protein [26, 30]. The tyrosine and valine residues are 
conserved in the R2lox group [4], and the cross-link was 
observed in both R2lox proteins that have been structur-
ally characterized [25, 26]. Both proteins also comprise a 
hydrophobic channel leading to the metal cofactor wherein 
a long-chain fatty acid molecule is found, which coordi-
nates at the Mn/Fe ions of the cofactor [25, 26].
The mixed-metal cofactor in R2lox self-assembles with 
the manganese ion in metal-binding site 1 and the iron ion 
in site 2 if both  MnII and  FeII are available [26]. Both a Mn/
Fe and a Fe/Fe cofactor, but not a Mn/Mn or Fe/Mn cofactor, 
can be assembled in R2lox, and both cofactor types activate 
 O2 and catalyze tyrosine–valine cross-link formation [30, 
31], with the Mn/Fe cofactor being more efficient in this 
reaction [32]. How discrimination between manganese and 
iron in the two metal binding sites is achieved has remained 
unclear. Structural as well as kinetic reasons for metal dis-
crimination have been discussed [26, 31, 33]. Our earlier 
studies of the wild-type R2lox protein showed that site 1 
is unspecific for manganese or iron in the absence of  O2, 
but prefers manganese in the presence of  O2, indicating that 
metal specificity may be achieved not solely during the ini-
tial metal binding step, but at a later stage of the cofactor 
assembly pathway [26, 31]. Here we investigated the effect 
of amino acid point mutations on the metal specificity, redox 
state of Mn/Fe and Fe/Fe cofactors, and cross-link formation 
capability of R2lox using metal content quantification, X-ray 
absorption spectroscopy, and protein crystallography. We 
find that site 1 is only specific for manganese under aerobic 
conditions if the cross-link residues have their wild-type 
identity. It thus appears that cross-link formation and assem-
bly of the heterodinuclear cofactor are synergistic.
Materials and methods
Site‑directed mutagenesis, protein production 
and purification
Point mutations were introduced into a construct encod-
ing full-length Geobacillus kaustophilus R2loxI (accession 
number WP_011232245) with an N-terminal hexahisti-
dine tag in pET-46 Ek/LIC (Novagen) [26] by site-directed 
mutagenesis using the QuikChange Lightning kit (Agilent) 
and verified by DNA sequencing. The point mutations dis-
cussed in this study are V72A/I/L [32] and Y162F, the resi-
dues forming an ether cross-link in the wild-type protein, as 
well as A171F, a residue lining the ligand-binding pocket in 
the second coordination sphere of the metal cofactor. The 
R2lox variants were produced and purified in metal-free 
form as described previously [26]. Briefly, the protein was 
produced recombinantly in E. coli BL21(DE3) (Novagen) 
grown in terrific broth (ForMedium). To obtain metal-free 
protein, 0.5 mM EDTA was added to the cultures imme-
diately before induction with 0.5 mM IPTG. Apo-protein 
was purified via heat denaturation of contaminating pro-
teins and nickel chelate affinity chromatography. Cells were 
disrupted by high-pressure homogenization in lysis buffer 
(25 mM HEPES-Na, pH 7.0; 300 mM NaCl, 20 mM imida-
zole, 0.5 mM EDTA). The lysate was cleared by centrifuga-
tion, incubated at 333 K for 10 min, and again cleared by 
centrifugation. The supernatant was applied to a Ni–NTA 
agarose (Protino, Macherey-Nagel) gravity flow column. The 
beads were washed with lysis buffer containing 40 mM imi-
dazole, followed by the same buffer lacking EDTA. Protein 
was then eluted using lysis buffer without EDTA containing 
250 mM imidazole. The eluate was exchanged into storage 
buffer (25 mM HEPES-Na, pH 7.0; 50 mM NaCl) using a 
HiTrap Desalting column (GE Healthcare). The protein was 
concentrated to approximately 1 mM, aliquoted, flash-fro-
zen in liquid nitrogen and stored at 193 K [26]. The protein 
concentration was measured using experimentally deter-
mined extinction coefficients at 280 nm [34]. The extinc-
tion coefficients are 47.8 mM−1 cm−1 or 50.6 mM−1 cm−1 
for metal-free or metal-bound wild-type R2lox [34] and all 
point mutants except Y162F-R2lox, and 43.9 mM−1 cm−1 
or 46.6 mM−1 cm−1 for metal-free or metal-bound Y162F-
R2lox, respectively. The metal contents of purified apo-pro-
tein batches were quantified by TXRF (see below).
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Crystallization and data collection
All R2lox variants were crystallized in metal-free form 
by vapor diffusion in hanging drops at 295 K. Wild-type, 
A171F- and V72I-R2lox crystallized in 25–30% (w/v) PEG 
1500, 100 mM HEPES-Na, pH 7.4–7.5. Only intergrown 
crystals containing multiple lattices could be obtained of 
Y162F-R2lox in the wild-type condition as well as upon 
re-screening, whereas the V72A and V72L mutants did 
not nucleate at all. To obtain single crystals of these three 
mutants, drops were, therefore, streak-seeded with wild-type 
R2lox crystals following a 1 h equilibration after setting up 
the hanging-drop plates, with the mother liquor contain-
ing 20–22.5% (w/v) PEG 1500 and 100 mM HEPES-Na, 
pH 6.8–7.0. Crystals grew in clusters along the streak line, 
but could easily be separated into large three-dimensional 
single crystals. To reconstitute the oxidized resting state 
Mn/Fe cofactor in R2lox point mutants, crystals of metal-
free protein were removed from their drop and soaked in 
mother liquor additionally containing 5 mM each  MnCl2 and 
 (NH4)2Fe(SO4)2 for 1–2 h under aerobic conditions and then 
briefly washed in 40% (w/v) PEG 1500, 100 mM HEPES-Na 
(at the pH of the mother liquor) before flash-cooling in liquid 
nitrogen. To obtain the non-activated reduced Mn/Fe cofac-
tor, apo-protein crystals were soaked in 1 ml of 40% (w/v) 
PEG 1500, 100 mM HEPES-Na (at the pH of the mother 
liquor), 5 mM  (NH4)2Fe(SO4)2, 5 mM  MnCl2, 0.5% (w/v) 
sodium dithionite, 0.5 mM phenosafranin, and 0.05% (v/v) 
Tween 20 for 1–2 h and flash-cooled directly without wash-
ing [26]. Soaking solutions were freshly prepared imme-
diately before use, using freshly dissolved  (NH4)2Fe(SO4)2 
and dithionite to ensure that the Fe was ferrous, and that 
 O2 was effectively removed from soaking solutions used to 
obtain reduced states, with phenosafranin serving as a redox 
indicator. We note that the soaking duration has been shown 
to have no effect on final active site metal contents [26]. Dif-
fraction data were collected at 100 K at beamlines X06SA 
and X10SA at the Swiss Light Source (SLS, Villigen, Swit-
zerland) and BL14.1 at BESSY (Helmholtz Center Berlin, 
Germany). For the purpose of metal quantification, data col-
lection proceeded in the order Fe K-edge—Mn K-edge on 
the same crystal. High-resolution data were collected after 
anomalous datasets.
Structure determination, model building, 
and refinement
Data were processed with XDS [35]. The structures of R2lox 
point mutants were solved using the structure of the wild-
type protein in the same redox state [26] not containing 
any ligands as a starting model. Crystals of A171F-R2lox 
were obtained in the same space group (I222) as the wild-
type with one molecule in the asymmetric unit, and these 
structures were consequently solved by Fourier synthesis. 
Crystals of the Y162F mutant were in space group C2 with 
two molecules in the asymmetric unit. These structures 
were, therefore, solved by molecular replacement using 
Phaser in Phenix [36, 37]. Refinement was carried out with 
phenix.refine [36, 38] and iterated with rebuilding in Coot 
[39]. Refinement generally included bulk solvent correc-
tions, individual atomic coordinate and isotropic B factor 
refinement, and occupancy refinement for alternate confor-
mations and metal ions bound on the protein surface, but not 
the active site metal ions. Metal–ligand bond lengths were 
restrained. Solvent molecules were added with phenix.refine 
as well as manually. Hydrogens were added to the models 
in the later stages of refinement. One exception was made 
to this general protocol: In the structure of reduced state 
Y162F-R2lox, anisotropic B factors were refined due to the 
sufficiently high resolution of the data (1.4 Å). Structures 
were validated using MolProbity [40]. Data and refinement 
statistics are given in Tables S1 and S2. Figures were pre-
pared with PyMOL (version 1.8.6.2, Schrodinger, LLC).
Analysis of anomalous diffraction data
All anomalous datasets were integrated over the same 
resolution range (50.0–3.0 Å) with XDS [35] (Table S1). 
The Fe and Mn edge datasets from one crystal were placed 
on a common scale with XSCALE [35]. Both scaled and 
unscaled datasets were analyzed. Anomalous difference 
maps were calculated with PHENIX [36] using the phases 
from a ligand-free model, and the relative amounts of Fe 
and Mn in each metal site were calculated as previously 
described [26]. The intensities of the anomalous difference 
density peaks in spheres of 1.9 Å radius around the center of 
the peaks were integrated using Mapman [41]. The relative 
amounts of Fe and Mn in each site were estimated from the 
integrated intensities at the Fe and Mn edges by taking into 
account the different contributions of both elements to the 
anomalous signal at the two wavelengths, assuming a total 
occupancy of each site of 1. Since only relative amounts are 
calculated, the actual occupancy is irrelevant as long as it is 
high enough to yield a significant anomalous peak, which 
was the case in all datasets. The quantification results for 
scaled and unscaled datasets matched within 10%.
X‑ray absorption spectroscopy (XAS)
To reconstitute oxidized resting-state Mn/Fe and Fe/Fe 
cofactors in the V72A-, Y162F- and A171F-R2lox vari-
ants as well as wt-R2lox for XAS analysis, 250 µM apo-
protein (monomer concentration) was incubated with 2 
equivalents (per monomer) of  MnCl2 and 1 equivalent of 
 (NH4)2Fe(SO4)2 or 3 equivalents of  (NH4)2Fe(SO4)2 only in 
reconstitution buffer (100 mM HEPES-Na, pH 7.0; 50 mM 
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NaCl) for 1 h at room temperature under aerobic condi-
tions. Excess metal ions were removed by passing the sam-
ples through a HiTrap Desalting column (GE Healthcare) 
equilibrated in storage buffer. The reconstituted protein was 
concentrated to 1–3.5 mM, transferred into sample holders 
and frozen in liquid nitrogen. XAS spectra at the Mn and 
Fe K-edges were collected at the SuperXAS beamline of 
SLS (Villigen, Switzerland) using a fluorescence-detection 
set-up (Si[111] double-crystal monochromator, 5-element 
silicon-drift detector, samples held in a liquid-He cryostat 
from Cryovac at 20 K) and previously described procedures 
for data collection, evaluation, and processing [30]. A linear 
fit to the pre-K-edge region was subtracted from the XAS 
spectra for background removal. The resulting XAS spectra 
were normalized (to an edge jump of unity) by division by a 
3rd-order polynomial through the post-K-edge region. X-ray 
absorption near edge structure (XANES) spectra were nor-
malized after averaging of up to 15 scans of approximately 
2 min duration on separate sample spots (using appropriate 
beam attenuation to avoid X-ray photoreduction of cofac-
tors), detector dead-time correction, and energy axis calibra-
tion. The monochromator energy axis was calibrated using 
the first inflection point at 7112.0 eV in the 1st derivative 
of the absorption spectrum of an iron foil (Fe K-edge) or 
the pre-edge peak maximum at 6543.3 eV in the absorption 
spectrum of a permanganate  (KMnO4) powder sample (Mn 
K-edge) as reference energies [42, 43].
Total‑reflection X‑ray fluorescence (TXRF) analysis 
of protein metal contents
To assess the cofactor assembly mechanism in solution, 
R2lox point mutants were reconstituted using different ratios 
of protein:Mn:Fe in reconstitution buffer at room tempera-
ture under aerobic conditions. Samples were prepared in 
duplicate. Mn titration series were prepared by adding 2, 4 or 
8 equivalents (per monomer) of  MnCl2 to 100 µM apo-pro-
tein prior to addition of 2 equivalents  (NH4)2Fe(SO4)2 and 
incubating the samples for 1 h. Fe titration series were pre-
pared by adding 4 equivalents of  MnCl2 to 100 µM apo-pro-
tein. Then, 0.2 equivalents of  (NH4)2Fe(SO4)2 were added 
from a 10 mM stock solution (i.e. protein:Mn:Fe = 1:4:0.2). 
After 20 min incubation, an aliquot was taken, and another 
0.4 equivalents of  (NH4)2Fe(SO4)2 were added to the remain-
ing solution (i.e. protein:Mn:Fe = 1:4:0.6). This step was 
repeated once more (i.e. protein:Mn:Fe = 1:4:1). All Fe titra-
tion samples were incubated for 1 h after the last addition of 
 (NH4)2Fe(SO4)2, i.e. for a total of 100 min. Following the 
reconstitution procedure, excess metal ions were removed 
by passing the samples through a HiTrap Desalting column 
(GE Healthcare) equilibrated in storage buffer. The samples 
were concentrated to approximately 0.5 mM protein, which 
was determined as above. Metal contents of apo-protein 
preparations and metal titration samples were quantified 
using TXRF analysis on a Bruker PicoFox instrument [44]. 
A gallium standard (Sigma) was added to the samples (v/v 
1:1) prior to the measurements. TXRF spectra were analyzed 
using the routines provided with the spectrometer.
Results
Five different amino acid point mutations were introduced 
in the R2lox scaffold, and their effects on the structure and 
metal specificity of the cofactor were investigated. Four 
mutations were made to the cross-linking residues, which are 
conserved in the R2lox group [4]. The valine was changed 
to alanine, isoleucine, or leucine (V72A/I/L) [32], and the 
tyrosine was changed to phenylalanine (Y162F). Moreover, 
A171, which lines the fatty-acid binding tunnel, was changed 
to phenylalanine (A171F). The latter mutation was designed 
to create a cofactor geometry in R2lox more closely resem-
bling the R2c site by blocking access of the fatty acid ligand 
that co-purifies with the wild-type protein and coordinates 
both metal ions. The A171 position is conserved as an ala-
nine in the R2lox family, whereas in the corresponding posi-
tion a phenylalanine is conserved among all groups of RNR 
R2 proteins [4].
Crystal structures of R2lox variants
The crystal structures of wt-R2lox and the V72 mutants in 
the non-activated reduced and  O2 oxidized resting state have 
previously been described [26, 30, 32], but will briefly be 
discussed here for comparison. In wt-R2lox, a manganese 
and an iron ion are bound next to each other in octahedral 
geometry by two histidine and four glutamate residues [26, 
30] (Fig. 1a). In addition to the amino acid ligands, a long-
chain fatty acid ligand bridges the metal ions and a water 
molecule is bound at the manganese ion in site 1. After oxi-
dation of the cofactor by  O2, a µ-hydroxo bridge displaces 
the C-terminal glutamate ligand from its bridging/chelating 
position, and an ether cross-link is formed between the Cβ 
of V72 and the phenolic oxygen of Y162 [26, 30, 33, 34]. 
Prior to cross-link formation, the hydroxyl group of Y162 
is hydrogen-bonded to the carbonyl oxygen of V72 [26, 
30]. Mutations of V72 have little effect on the global struc-
tures of the reduced and oxidized resting cofactor states and 
cause only minor changes to the metal coordination geom-
etry. Importantly, none of the mutations appears to inhibit 
 O2 reduction and metal oxidation, but mutation of V72 to 
alanine or leucine prevents cross-link formation, whereas 
tyrosine–isoleucine cross-link formation is observed with 
an isoleucine in place of the native valine [32].
The mutation of the cross-link tyrosine to a phenyla-
lanine was found to have little effect on the active site 
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and global protein structure of R2lox, although the hydro-
gen bond to the carbonyl oxygen of V72 is missing in the 
reduced state and the cross-link cannot be formed upon 
oxidation (Fig. 1b). Interestingly, in the structure of the 
aerobically reconstituted protein, only one of the two subu-
nits of the dimer in the asymmetric unit of the crystals 
is in the oxidized state conformation. Very weak differ-
ence density for the oxidized conformation in the other 
subunit suggested that the reduced state conformation 
was present in at least 90% of this molecule (not shown). 
This asymmetric behavior might be caused by different 
packing interactions of the two molecules in the crystal. 
It should be noted, however, that other mutants that crys-
tallized in the same space group (V72A/L-R2lox) did not 
display large differences between the two subunits [32]. 
It appears, therefore, that the asymmetry is caused by the 
Y162F mutation, either because  O2 activation is partially 
impaired in Y162F-R2lox, or because one subunit is more 
sensitive to X-ray photoreduction during diffraction data 
collection, an effect previously observed in a related class 
Ib R2 protein [45].
In A171F-R2lox, the fatty acid is excluded from the 
active site because the bulky phenylalanine side chain blocks 
the ligand-binding tunnel (Fig. 1c). Electron density for a 
hydrophobic ligand is observed further up in the tunnel, but 
it could only reasonably be modeled (as caprylic  (C8) acid) 
in the oxidized state. Similar to the V72L variant [32], in the 
reduced state of A171F-R2lox, E167 ligates Fe2 in bidentate 
mode instead of the monodentate ligation in the wild-type, 
so that Fe2 adopts a near-octahedral geometry as in the pres-
ence of the fatty acid ligand, while Mn1 appears to have 
an unoccupied coordination site. The other metal ligands 
retain the same spatial configuration as in the wild-type. 
In contrast, in the oxidized state of A171F-R2lox, E167 is 
a monodentate ligand to Fe2 as in the wild-type, whereas 
E202 adopts the oxidized or reduced state conformation 
in roughly equal proportions. However, cofactor oxidation 
by  O2 appears to have taken place regardless of the E202 
conformation, because an oxo/hydroxo bridge is clearly 
observed in the electron density in the position occupied by 
the fatty acid head group in the wild-type. It appears likely 
that in those molecules in which E202 is in the oxidized 
Fig. 1  Active site structures of R2lox variants in the non-activated 
reduced (top panel) and  O2-oxidized resting state (bottom panel). All 
structures are shown in roughly the same orientation, with site 1 on 
the left. Mutated residues are highlighted in orange. Metal–ligand 
bonds are indicated by grey lines, hydrogen bonds by dashed blue 
lines. The insets show mFo–DFc refined omit electron density con-
toured at 3.0σ for residues 72 and 162 in oxidized state crystals. a 
wt-R2lox (reduced state, PDB ID 4HR4; oxidized state, PDB ID 
4HR0) [26]: an ether cross-link is formed between the Cβ of V72 and 
the hydroxyl oxygen of Y162 in the oxidized state. b Y162F-R2lox: 
no ether cross-link is formed. c A171F-R2lox: the V72-Y162 ether 
cross-link is formed. In the oxidized state, E202 (labeled in red) is 
observed in two alternate conformations, one leading to a hexacoor-
dinate Fe ion, the other leaving one coordination site vacant, unless a 
second oxo/hydroxo bridge (not modeled) takes its place (the metal–
ligand bonds of both conformations are indicated)
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state conformation, a second oxo/hydroxo species occupies 
the bridging position. Accordingly, the A171F-R2lox cofac-
tor can adopt a geometry which is similar to the oxidized 
cofactor in R2c [29], with two oxygen bridges instead of 
only one as in wt-R2lox. However, none of these structural 
changes seem to have an effect on cofactor reactivity with 
respect to cross-link formation. Judging from the electron 
density, the cross-link was formed equally efficiently in the 
presence of  O2 in A171F-R2lox as in the wild-type protein 
(Fig. 1c, inset).
Metal oxidation states in aerobically reconstituted 
R2lox variants
X-ray absorption spectroscopy was carried out on selected 
R2lox variants to study the metal oxidation state (Fig. 2). 
The Mn K-edge spectra of Mn/Fe-reconstituted samples and 
the Fe K-edge spectra of Fe/Fe-reconstituted wt-, V72A-, 
Y162F-, and A171F-R2lox prepared under aerobic condi-
tions were very similar, confirming the overall similar, near-
octahedral metal coordination observed in the crystals. The 
almost identical K-edge energies (Fe, 7124.8 ± 0.1 eV; Mn, 
6549.2 ± 0.1 eV; at 50% edge-rise level) of all variants were 
similar to our previously determined K-edge energies (Fe, 
7124.8 ± 0.1 eV; Mn, 6549.3 ± 0.1 eV) of the oxidized wild-
type protein [30], indicating the near-quantitative presence 
of  MnIII and  FeIII. Accordingly, all R2lox variants assem-
ble (Mn/Fe)III/FeIII cofactors in the presence of  O2, inde-
pendently of the metal ligation motif and ability to form 
the cross-link. No impairment of  O2 reduction could be 
observed in Y162F-R2lox in solution. This suggests that 
enhanced sensitivity to photoreduction was the reason for 
the reduced state conformation that is prevalent in one of 
the two subunits of the oxidized state Y162F-R2lox crystal 
structure (see above).
Metal distribution in the active site of R2lox variants 
following crystal soaking
To investigate whether the point mutations have an effect 
on metal specificity, we soaked metal-free protein crystals 
with an excess of both metal(II) ions in equal concentra-
tions under anoxic and aerobic conditions and analyzed the 
relative amounts of Mn and Fe in each metal-binding site 
using X-ray anomalous dispersion, as previously done with 
the wild-type protein [26] (Fig. 3). In wt-R2lox, roughly 1:1 
Mn:Fe accumulate in site 1 and mainly Fe in site 2 under 
anoxic conditions, whereas under aerobic conditions site 2 
also contains mainly Fe, but site 1 contains almost exclu-
sively Mn [26]. The same metal distribution was observed in 
A171F-R2lox. In stark contrast, in all four cross-link residue 
mutants, site 1 contained roughly 1:1 Mn:Fe under anoxic 
as well as under aerobic conditions, while the metal dis-
tribution in site 2 was about the same as in the wild-type. 
In V72A/L- and Y162F-R2lox, both subunits of the dimer 
in the asymmetric unit had the same metal distribution. It 
should be noted that the difference between the metal con-
tents in wt- and A171F-R2lox on the one hand and the cross-
link mutants on the other hand cannot be attributed to the 
different crystallographic space groups these R2lox variants 
adopt, nor to the different pH values of the crystallization 
mother liquor. While the V72A/L and Y162F mutants crys-
tallized in a different space group and at a lower pH than the 
wild-type (and required seeding with wild-type crystals), 
Fig. 2  X-ray absorption spectra 
of aerobically metal-reconsti-
tuted wt-, V72A-, Y162F- and 
A171F-R2lox variants. a Fe 
K-edge spectra of Fe-only 
reconstituted variants; b Mn 
K-edge spectra of Mn/Fe-recon-
stituted variants. The spectra of 
solid  FeIII or  MnIII oxides are 
shown for comparison
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V72I-R2lox crystallized in the same space group and at 
the same pH as wt-R2lox (see Materials and Methods and 
Supporting Information, Table S1). It should also be noted 
that the V72A/L- and Y162F variants do not form the ether 
cross-link, while the V72I variant does, but the metal distri-
bution is virtually identical in all these variants and unlike 
that of the wild-type.
Metal contents of R2lox variants after reconstitution 
in aerobic solution
We also investigated the metal binding behavior of the R2lox 
variants in solution for comparison with the crystallographic 
results. Only up to 0.6 Mn/protein are accumulated in wt-
R2lox in solution when Mn is in excess and Fe is substoichi-
ometric, whereas stoichiometric amounts of Mn and Fe lead 
to more Fe/Fe than Mn/Fe centers being formed [31]. Here, 
we reconstituted wt-R2lox and the five variants with  MnII 
and  FeII at different protein:Mn:Fe ratios in aerobic solution 
and analyzed the metal contents of the proteins by TXRF 
after removal of excess metal ions. The apo-protein prepara-
tions were also analyzed and found to contain no more than 
0.1 Fe/protein and no significant amounts of other transition 
metals. As suggested by previous analyses [31], cofactor dis-
tributions were calculated assuming that all metal is bound 
in dinuclear centers and that stoichiometric manganese is 
incorporated in Mn/Fe sites (with Mn in site 1 as observed in 
crystals). In contrast to the crystallographic experiments, in 
solution none of the mutations had a significant effect on the 
metal contents of the R2lox variants compared to the wild-
type (Fig. 4). Reconstitution with 2 equivalents of Fe and 2, 
4, or 8 equivalents of Mn led to significant amounts of diiron 
clusters, and a maximum of approximately 60–70% of the 
protein contained Mn/Fe cofactors, in agreement with our 
earlier results [31]. When up to 1 equivalent Fe was slowly 
titrated in after addition of 4 equivalents Mn to the protein, 
a maximum of 0.7 Mn/Fe clusters per protein was obtained, 
but under these conditions the remaining protein was largely 
metal free, with only approximately 10% occupied by dii-
ron centers, again in agreement with earlier data [31]. The 
data suggest that, in contrast to the wild-type, V72A/I- and 
Y162F-R2lox accumulated a small amount of Mn/Mn cofac-
tors when only 0.2 equivalents of Fe had been added. How-
ever, the amount of Mn per protein which was surplus to the 
Fig. 3  Relative amounts of Mn and Fe in metal sites 1 (a, c) and 2 
(b, d) of R2lox variants following crystal soaking with  MnII and  FeII 
in the absence (a, b) or in the presence (c, d) of  O2, compared to wt-
R2lox [26]. The column height of 1 refers to the sum of Mn and Fe 
in each metal site. Metal-free protein crystals were soaked with an 
excess of  MnII and  FeII in equal concentrations under reducing anoxic 
(0.5% sodium dithionite) or aerobic conditions (air-saturated buffer). 
Relative metal amounts are derived from the integrated intensity of 
the anomalous difference density peaks at the Mn and Fe absorption 
edges. Data stem from at least 2 crystals in space group C2 with two 
molecules per asymmetric unit, or at least 4 crystals in space group 
I222 with one molecule per asymmetric unit, i.e. at least 4 independ-
ent observations of each site (see Table S1). Error bars show standard 
deviations of the replicates
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amount of Fe in these samples is within the error range of 
the quantification. Under the present solution conditions, 
all studied R2lox variants, therefore, showed similar metal 
binding site occupation as the wild-type.
Discussion
We show here that the cross-link residues are required for 
efficient assembly of the Mn/Fe cofactor in R2lox. Unlike 
the mutation of A171 in the fatty-acid binding tunnel to phe-
nylalanine, a mutation in either of the cross-link residues, 
even if it does not prevent cross-link formation, abolishes 
the manganese specificity of site 1 observed in the wild-type 
protein. Together with the results from the metal reconstitu-
tion procedure variations, the mutational data provide fur-
ther insight into the cofactor assembly pathway of R2lox.
R2lox displays different metal preferences in the absence 
and presence of  O2, indicating that site-selective metal 
specificity is determined by a combination of the protein 
scaffold’s intrinsic metal(II) preferences and differential 
preferences for metal(III) ions established during  O2 bind-
ing and/or reduction. In the wild-type protein, site 2 always 
prefers iron, while site 1 is unspecific for  MnII or  FeII under 
anoxic conditions, but strongly prefers  MnIII over  FeIII under 
aerobic conditions [26]. We have previously proposed that 
manganese is preferred in site 1 because the presence of a 
terminal water ligand pre-adapts this site for accommoda-
tion of a  MnIII (pseudo-) Jahn–Teller ion with its axis along 
the Mn–water bond, whereas the octahedral site 2, which 
contains only terminal amino acid ligands, is more suitable 
for iron binding [31, 33].
The preference for manganese in site 1 is more clearly 
observed in the crystal soaking experiments compared to 
solution conditions [26, 31], suggesting that the ratio of 
available metal ions to protein plays an important role in 
cofactor assembly. In the crystal soaking experiments, metal 
ions were in large excess and, taking into account the low 
 O2 concentration (approximately 0.25 mM in  O2-saturated 
buffer at room temperature), metal exchange may be faster 
Fig. 4  Mn and Fe contents of R2lox variants after reconstitution with 
 MnII and  FeII in solution, as determined by TXRF. a Mn titration; b 
Fe titration. X axis labels denote protein:Mn:Fe ratios in the cofactor 
reconstitution. Column heights show the sum of Mn and Fe per pro-
tein in the top panels and of Mn/Fe, Fe/Fe and Mn/Mn cofactor con-
tent in the bottom panels. Shown are mean values from two independ-
ent measurements each on duplicate samples. The error is less than or 
equal to 0.1 metal ions per protein. Other transition metals (Ni, Cu, 
Zn) were negligible in all samples. Proportions of metal center spe-
cies in the bottom panel were calculated assuming that all metal ions 
are bound in dinuclear centers and that formation of heterodinuclear 
clusters is preferred
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than  O2 reduction under these conditions [46], so that the 
preferred cofactor configuration can be formed before  O2 
activation is completed, and the relative Mn/Fe cofactor con-
tent is thereby increased. In solution, protein precipitation 
prevents the use of a large excess of metal ions. Under these 
conditions, with near-stoichiometric metal(II) to protein 
ratios, any initially formed, catalytically competent cofactor, 
i.e.  MnII/FeII or  FeII/FeII [30, 31], is stabilized in a higher-
valent state because metal exchange is likely considerably 
slower than  O2 reduction [46], so that the final metal content 
of the protein is determined primarily by the metal(II) pref-
erences of the sites, similarly to the anoxic crystal soaks. 
The results shown here demonstrate that the studied second-
sphere mutations do not influence the metal(II) preferences 
of R2lox, suggesting that these preferences are primarily 
determined by the structure of the first ligand sphere. How-
ever, the metal(II) affinity of R2lox is generally low, whereas 
under aerobic conditions dinuclear metal(III) cofactors 
are efficiently stabilized [31, 46], presumably because the 
stronger metal–ligand bonds and the metal-bridging oxide 
stabilize the metal(III)-containing cofactors.
The R2lox variants with exchanged cross-link residues 
show that the native cross-link residues are required to 
achieve the manganese preference of site 1 under aerobic 
conditions. The different metal preferences of the cross-
link mutants in comparison to the wild-type protein are not 
caused by a lack of  O2 reduction and metal oxidation, as 
the crystal structures and the XAS data demonstrate that all 
variants activate oxygen [32]. Like the wild-type [30, 33], 
the Y162F and V72A mutants assemble mostly (Mn/Fe)III/
FeIII cofactors, suggesting that in the absence of cross-link 
formation, putative metal(IV) species formed after full  O2 
reduction are partially reduced by external electron sources. 
Such unspecific reduction, as well as metal reduction in the 
course of cross-link formation in V72I-R2lox, however, pre-
sumably occur at a different rate than reduction by cross-link 
formation in the wild-type. We, therefore, propose that the 
cross-link residues and the actual cross-link formation in wt-
R2lox control the decay rate of initial high-valent states of 
the cofactor, which, in relation to the rate of metal exchange, 
leads to the preferential assembly of  MnIII/FeIII cofactors. 
We note that this would require that some steps of the oxy-
gen reduction mechanism are reversible. In support of this 
hypothesis, we have recently shown that the Mn/Fe cofactor 
catalyzes cross-link formation more efficiently than its diiron 
counterpart in wt-R2lox [32]. Taken together, these results 
indicate that assembly of the heterodinuclear Mn/Fe cofactor 
is coupled to cross-link formation.
Cofactor assembly in R2lox thus appears to be controlled 
by a combination of thermodynamic and kinetic effects and 
to be highly dependent on the relative rates of  MnII,  FeII 
and  O2 access, prompting the question whether this mecha-
nism is relevant in vivo. While total metal concentrations in 
the cell are in the mM range, similar to the crystal soaking 
conditions, the amount of free metal is expected to be very 
low [47], more similar to the solution conditions described 
here. Which amounts of metal ions are accessible to the pro-
tein at which rates in competition with the numerous other 
chelators in the cell, as well as the rate of  O2 supply, is a 
difficult problem to approach experimentally and thus also 
to reproduce in vitro. Moreover, expression in heterologous 
hosts and/or overexpression, in general, will also result in 
conditions for cofactor assembly that differ from those in 
the native host at native expression levels. This challenge 
is principally encountered when addressing metal cofactor 
assembly mechanisms for all metalloproteins for which no 
specific metallochaperone-mediated assembly pathway is 
present. Most likely, this concerns the vast majority of Fe 
and Mn-cofactor proteins.
Here, we describe two different in vitro conditions for 
cofactor assembly, in solution with low metal concentration 
and in crystals with high metal concentration. While the first 
may intuitively appear more similar to the in vivo situation, 
we note that when R2lox is produced aerobically in vivo 
without added metal chelators, the resulting protein contains 
predominantly heterodinuclear Mn/Fe cofactors [25]. Thus, 
the crystal soaking experiments, in fact, appear to better 
reflect the in vivo outcome than the solution reconstitution 
experiments. In summary, these data imply that the biologi-
cally relevant form of R2lox contains both a Mn/Fe cofactor 
and the tyrosine–valine cross-link.
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